Selected research
Industry Research
Malaria Drugs Industry Research Report 2026
Market perspective
The global Malaria Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Malaria Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Malaria Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Malaria Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Malaria Drugs include Ajanta Pharma, Cipla, Guilin Pharmaceutical, IPCA Laboratories, Sanofi Aventis, GlaxoSmithKline, Kunming Pharmaceutical, Roche and Mylan Labs, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Malaria Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Malaria Drugs Market by Company
Ajanta Pharma
Cipla
Guilin Pharmaceutical
IPCA Laboratories
Sanofi Aventis
GlaxoSmithKline
Kunming Pharmaceutical
Roche
Mylan Labs
Novartis
Malaria Drugs Segment by Type
Artemisinin Compounds
Antifolate Compounds
Aryl Aminoalcohol Compounds
Malaria Drugs Segment by Application
Prevention
Treatment
Other
Malaria Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Malaria Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Malaria Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Malaria Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Malaria Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Malaria Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Malaria Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Artemisinin Compounds
- Antifolate Compounds
- Aryl Aminoalcohol Compounds
Applications
- Prevention
- Treatment
- Other
Companies covered
- Ajanta Pharma
- Cipla
- Guilin Pharmaceutical
- IPCA Laboratories
- Sanofi Aventis
- GlaxoSmithKline
- Kunming Pharmaceutical
- Roche
- Mylan Labs
- Novartis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Malaria Drugs Market Size (2021-2032)
- 2.2.2 Global Malaria Drugs Sales (2021-2032)
- 2.2.3 Global Malaria Drugs Market Average Price (2021-2032)
- 2.3 Malaria Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Artemisinin Compounds
- 2.3.3 Antifolate Compounds
- 2.3.4 Aryl Aminoalcohol Compounds
- 2.4 Malaria Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Prevention
- 2.4.3 Treatment
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Malaria Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Malaria Drugs Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Malaria Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Malaria Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Malaria Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Malaria Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Malaria Drugs, Product Type & Application
- 3.8 Global Manufacturers of Malaria Drugs, Established Date
- 3.9 Global Malaria Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Ajanta Pharma
- 4.1.1 Ajanta Pharma Company Information
- 4.1.2 Ajanta Pharma Business Overview
- 4.1.3 Ajanta Pharma Malaria Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Ajanta Pharma Malaria Drugs Product Portfolio
- 4.1.5 Ajanta Pharma Recent Developments
- 4.2 Cipla
- 4.2.1 Cipla Company Information
- 4.2.2 Cipla Business Overview
- 4.2.3 Cipla Malaria Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Cipla Malaria Drugs Product Portfolio
- 4.2.5 Cipla Recent Developments
- 4.3 Guilin Pharmaceutical
- 4.3.1 Guilin Pharmaceutical Company Information
- 4.3.2 Guilin Pharmaceutical Business Overview
- 4.3.3 Guilin Pharmaceutical Malaria Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Guilin Pharmaceutical Malaria Drugs Product Portfolio
- 4.3.5 Guilin Pharmaceutical Recent Developments
- 4.4 IPCA Laboratories
- 4.4.1 IPCA Laboratories Company Information
- 4.4.2 IPCA Laboratories Business Overview
- 4.4.3 IPCA Laboratories Malaria Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 IPCA Laboratories Malaria Drugs Product Portfolio
- 4.4.5 IPCA Laboratories Recent Developments
- 4.5 Sanofi Aventis
- 4.5.1 Sanofi Aventis Company Information
- 4.5.2 Sanofi Aventis Business Overview
- 4.5.3 Sanofi Aventis Malaria Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sanofi Aventis Malaria Drugs Product Portfolio
- 4.5.5 Sanofi Aventis Recent Developments
- 4.6 GlaxoSmithKline
- 4.6.1 GlaxoSmithKline Company Information
- 4.6.2 GlaxoSmithKline Business Overview
- 4.6.3 GlaxoSmithKline Malaria Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 GlaxoSmithKline Malaria Drugs Product Portfolio
- 4.6.5 GlaxoSmithKline Recent Developments
- 4.7 Kunming Pharmaceutical
- 4.7.1 Kunming Pharmaceutical Company Information
- 4.7.2 Kunming Pharmaceutical Business Overview
- 4.7.3 Kunming Pharmaceutical Malaria Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Kunming Pharmaceutical Malaria Drugs Product Portfolio
- 4.7.5 Kunming Pharmaceutical Recent Developments
- 4.8 Roche
- 4.8.1 Roche Company Information
- 4.8.2 Roche Business Overview
- 4.8.3 Roche Malaria Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Roche Malaria Drugs Product Portfolio
- 4.8.5 Roche Recent Developments
- 4.9 Mylan Labs
- 4.9.1 Mylan Labs Company Information
- 4.9.2 Mylan Labs Business Overview
- 4.9.3 Mylan Labs Malaria Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Mylan Labs Malaria Drugs Product Portfolio
- 4.9.5 Mylan Labs Recent Developments
- 4.10 Novartis
- 4.10.1 Novartis Company Information
- 4.10.2 Novartis Business Overview
- 4.10.3 Novartis Malaria Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Novartis Malaria Drugs Product Portfolio
- 4.10.5 Novartis Recent Developments
5 Global Malaria Drugs Market Scenario by Region
- 5.1 Global Malaria Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Malaria Drugs Sales by Region: 2021-2032
- 5.2.1 Global Malaria Drugs Sales by Region: 2021-2026
- 5.2.2 Global Malaria Drugs Sales by Region: 2027-2032
- 5.3 Global Malaria Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Malaria Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Malaria Drugs Revenue by Region: 2027-2032
- 5.4 North America Malaria Drugs Market Facts & Figures by Country
- 5.4.1 North America Malaria Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Malaria Drugs Sales by Country (2021-2032)
- 5.4.3 North America Malaria Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Malaria Drugs Market Facts & Figures by Country
- 5.5.1 Europe Malaria Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Malaria Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Malaria Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Malaria Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Malaria Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Malaria Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Malaria Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Malaria Drugs Market Facts & Figures by Country
- 5.7.1 South America Malaria Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Malaria Drugs Sales by Country (2021-2032)
- 5.7.3 South America Malaria Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Malaria Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Malaria Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Malaria Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Malaria Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Malaria Drugs Sales by Type (2021-2032)
- 6.1.1 Global Malaria Drugs Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Malaria Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Malaria Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Malaria Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Malaria Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Malaria Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Malaria Drugs Sales by Application (2021-2032)
- 7.1.1 Global Malaria Drugs Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Malaria Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Malaria Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Malaria Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Malaria Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Malaria Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Malaria Drugs Value Chain Analysis
- 8.1.1 Malaria Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Malaria Drugs Production Mode & Process
- 8.2 Malaria Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Malaria Drugs Distributors
- 8.2.3 Malaria Drugs Customers
9 Global Malaria Drugs Analyzing Market Dynamics
- 9.1 Malaria Drugs Industry Trends
- 9.2 Malaria Drugs Industry Drivers
- 9.3 Malaria Drugs Industry Opportunities and Challenges
- 9.4 Malaria Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst